“Multiple Myeloma Molecular Monitoring Study”
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study